Dr. Edginton has been invited to the Bill & Melinda Gates Medical Research Institute event -- 2018 PD Challenge Workshop: Collaborating to Improve Translational Medicine in Global Health being held April 26-27, 2018 at the Boston Marriott Copley Place.
The 2018 American Society for Clinical Pharmacology and Therapeutics (ASCPT) Annual Meeting is in Orlando, FL on March 21-24. The following abstracts will be presented:
Malik PRV, Edginton AN. Pediatric physiology in relation to the disposition of monoclonal antibodies.
Dr. Edginton will moderate a two hour workshop on pharmacokinetics in hemophilia at the 9th Annual Bayer Hemophilia Conference. The conference runs from November 2-4, 2017 in Amsterdam, NL.
“Drugs in Lactation” Analysis Consortium (DLAC)
A new website has been created to aid in recruitment of breastfeeding mothers for the DLAC project (www.thedlac.com).
See the University of Waterloo, School of Pharmacy Facebook page (https://www.facebook.com/UWPharmacy/) to hear PhD candidate, Paul Malik, speak about his research using mathematical models to analyze how cancer drug concentrations change in the body over time in virtual children.
Dr. Pierre Chelle has joined the Edginton lab as a postdoctoral fellow.
Dr. Chelle recently completed his PhD at the Ecole Nationale Supérieure des Mines de Saint-Etienne, Saint-Etienne, France. The subject of his thesis was: Thrombin generation modeling in the framework of hemophilia treatment.
Dr. Edginton is a member of the “Drugs in Lactation” Analysis Consortium (DLAC). DLACis a network of scientists who explore drug safety during breastfeeding. The network is designed for collection of patient breast milk samples in a real world setting, to generate pharmacokinetic information (how drugs are absorbed, distributed in body and metabolized). This information enables the researchers to predict drug levels in human milk and infant blood in a population.
DLAC is headed by Dr. Shinya Ito and is housed at SickKids in Toronto, ON, Canada.
Dr. Anil Maharaj recently defended and has received the W.B. Pearson Medal from the Faculty of Science for recognition of creative research as presented in his Ph.D. thesis.
Dr. Maharaj was also awarded, based on the strength of his academic accomplishments, an “Outstanding Achievement in Graduate Studies” honour from the University of Waterloo.
Dr. Maharaj is currently a postdoctoral fellow at St. Jude Children's Research Hospital in Memphis, TN.
Alanna McEneny-King, a PhD student in Dr. Edginton's lab, has received a three-year CIHR Doctoral Award. She was ranked 3rd out of 479 applicants in her pool across Canada. This award is testament to the tenacity, intellect and creativity she has demonstrated during the past 1.5 years of her PhD. The Edginton lab congratulates Alanna on all of her accomplishments!
Dr. Edginton has joined the Board of Directors of the Centre for Bioengineering and Biotechnology (CBB) for a two year term starting January 2017. The Board of Directors is key to CBB's growth and the development of innovative research and research opportunities within industry and healthcare institutions both internationally and locally.